Chu, S., Ma, Y., Feng, D., Li, Z., & Jiang, P. (2013). Predictive value of the SLC22A18 protein expression in glioblastoma patients receiving temozolomide therapy. BioMed Central.
Citação norma ChicagoChu, Sheng-Hua, Yan-Bin Ma, Dong-Fu Feng, Zhi-Qiang Li, and Pu-Cha Jiang. Predictive Value of the SLC22A18 Protein Expression in Glioblastoma Patients Receiving Temozolomide Therapy. BioMed Central, 2013.
MLA citiranjeChu, Sheng-Hua, et al. Predictive Value of the SLC22A18 Protein Expression in Glioblastoma Patients Receiving Temozolomide Therapy. BioMed Central, 2013.
Opozorilo: Ti citati niso vedno 100% točni.